BACKGROUND AND PURPOSE: The formation of reactive astrocytes is common after central nervous system injuries such as stroke. However, the signaling pathway(s) that control astrocyte formation and functions are poorly defined. We assess the effects of Notch 1 signaling in peri-infarct-reactive astrocytes after stroke. METHODS: We examined reactive astrocyte formation in the peri-infarct area 3 days after distal middle cerebral artery occlusion with or without γ-secretase inhibitor treatment. To directly study the effects of inhibiting a γ-secretase cleavage target in reactive astrocytes, we generated glial fibrillary acidic protein-CreER™:Notch 1 conditional knockout mice. RESULTS: Gamma-secretase inhibitor treatment after stroke decreased the number of proliferative glial fibrillary acidic protein-positive reactive astrocytes and RC2-positive reactive astrocytes directly adjacent to the infarct core. The decrease in reactive astrocytes correlated with an increased number of CD45-positive cells that invaded into the peri-infarct area. To study the influence of reactive astrocytes on immune cell invasion, ex vivo immune cell invasion assays were performed. We found that a γ-secretase-mediated pathway in astrocytes affected Jurkat cell invasion. After tamoxifen treatment, glial fibrillary acidic protein-CreER™:Notch 1 conditional knockout mice had a significantly decreased number of proliferating reactive astrocytes and RC2-positive reactive astrocytes. Tamoxifen treatment also led to an increased number of CD45-positive cells that invaded the peri-infarct area. CONCLUSIONS: Our results demonstrate that proliferating and RC2-positive reactive astrocytes are regulated by Notch 1 signal transduction and control immune cell invasion after stroke.
BACKGROUND AND PURPOSE: The formation of reactive astrocytes is common after central nervous system injuries such as stroke. However, the signaling pathway(s) that control astrocyte formation and functions are poorly defined. We assess the effects of Notch 1 signaling in peri-infarct-reactive astrocytes after stroke. METHODS: We examined reactive astrocyte formation in the peri-infarct area 3 days after distal middle cerebral artery occlusion with or without γ-secretase inhibitor treatment. To directly study the effects of inhibiting a γ-secretase cleavage target in reactive astrocytes, we generated glial fibrillary acidic protein-CreER™:Notch 1 conditional knockout mice. RESULTS: Gamma-secretase inhibitor treatment after stroke decreased the number of proliferative glial fibrillary acidic protein-positive reactive astrocytes and RC2-positive reactive astrocytes directly adjacent to the infarct core. The decrease in reactive astrocytes correlated with an increased number of CD45-positive cells that invaded into the peri-infarct area. To study the influence of reactive astrocytes on immune cell invasion, ex vivo immune cell invasion assays were performed. We found that a γ-secretase-mediated pathway in astrocytes affected Jurkat cell invasion. After tamoxifen treatment, glial fibrillary acidic protein-CreER™:Notch 1 conditional knockout mice had a significantly decreased number of proliferating reactive astrocytes and RC2-positive reactive astrocytes. Tamoxifen treatment also led to an increased number of CD45-positive cells that invaded the peri-infarct area. CONCLUSIONS: Our results demonstrate that proliferating and RC2-positive reactive astrocytes are regulated by Notch 1 signal transduction and control immune cell invasion after stroke.
Authors: Andreas Androutsellis-Theotokis; Ronen R Leker; Frank Soldner; Daniel J Hoeppner; Rea Ravin; Steve W Poser; Maria A Rueger; Soo-Kyung Bae; Raja Kittappa; Ronald D G McKay Journal: Nature Date: 2006-06-25 Impact factor: 49.962
Authors: T Nihashi; S Inao; Y Kajita; T Kawai; T Sugimoto; M Niwa; R Kabeya; N Hata; S Hayashi; J Yoshida Journal: Acta Neurochir (Wien) Date: 2001 Impact factor: 2.216
Authors: Joseph F Arboleda-Velasquez; Zhipeng Zhou; Hwa Kyoung Shin; Angeliki Louvi; Hyung-Hwan Kim; Sean I Savitz; James K Liao; Salvatore Salomone; Cenk Ayata; Michael A Moskowitz; Spyros Artavanis-Tsakonas Journal: Proc Natl Acad Sci U S A Date: 2008-03-17 Impact factor: 11.205
Authors: Benjamin Bakondi; Issei S Shimada; Anthony Perry; James R Munoz; Joni Ylostalo; Alan B Howard; Carl A Gregory; Jeffrey L Spees Journal: Mol Ther Date: 2009-08-18 Impact factor: 11.454
Authors: Lizhen Li; Andrea Lundkvist; Daniel Andersson; Ulrika Wilhelmsson; Nobuo Nagai; Andrea C Pardo; Christina Nodin; Anders Ståhlberg; Karina Aprico; Kerstin Larsson; Takeshi Yabe; Lieve Moons; Andrew Fotheringham; Ioan Davies; Peter Carmeliet; Joan P Schwartz; Marcela Pekna; Mikael Kubista; Fredrik Blomstrand; Nicholas Maragakis; Michael Nilsson; Milos Pekny Journal: J Cereb Blood Flow Metab Date: 2007-08-29 Impact factor: 6.200
Authors: Manoj K Pandey; Bokyung Sung; Ajaikumar B Kunnumakkara; Gautam Sethi; Madan M Chaturvedi; Bharat B Aggarwal Journal: Cancer Res Date: 2008-07-01 Impact factor: 12.701
Authors: Gulnaz Begum; Shanshan Song; Shaoxia Wang; Hanshu Zhao; Mohammad Iqbal H Bhuiyan; Eric Li; Rachel Nepomuceno; Qing Ye; Ming Sun; Michael Joseph Calderon; Donna B Stolz; Claudette St Croix; Simon C Watkins; Yinhuai Chen; Pingnian He; Gary E Shull; Dandan Sun Journal: Glia Date: 2017-09-19 Impact factor: 7.452